D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ESLAW holding history
Estrella Immunopharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ESLAW overviewAll 13F holders of ESLAWFull Q2 2026 holdings
- Shares (Q2 2026)
- 87,500
- Value
- $12.5K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 87,500 | $12.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 87,500 | $6.13K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 87,500 | $4.38K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 87,500 | $4.55K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 87,500 | $3.81K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 87,500 | $6.74K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 87,500 | $7.69K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 87,500 | $6.13K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 87,500 | $6.93K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 87,500 | $6.05K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 87,500 | $4.26K | <0.1% | +87,500 | New | Holders |